CLINICAL INTEGRATION: CLINICAL INTEGRATION: TWENTY PRACTICAL - - PowerPoint PPT Presentation

clinical integration clinical integration twenty
SMART_READER_LITE
LIVE PREVIEW

CLINICAL INTEGRATION: CLINICAL INTEGRATION: TWENTY PRACTICAL - - PowerPoint PPT Presentation

CLINICAL INTEGRATION: CLINICAL INTEGRATION: TWENTY PRACTICAL TWENTY PRACTICAL CONSIDERATIONS CONSIDERATIONS Jeff Miles jjmiles@ober.com Christi Braun cjbraun@ober.com w w w .ober.com 1. Determine if clinical integration is simply one


slide-1
SLIDE 1

w w w .ober.com

CLINICAL INTEGRATION: CLINICAL INTEGRATION: TWENTY PRACTICAL TWENTY PRACTICAL CONSIDERATIONS CONSIDERATIONS

Jeff Miles

jjmiles@ober.com

Christi Braun

cjbraun@ober.com

slide-2
SLIDE 2
  • 1. Determine if clinical

integration is simply

  • ne more fad that w ill

pass.

slide-3
SLIDE 3
  • 2. Do clinical integration

for the right reasons.

slide-4
SLIDE 4
  • 3. Clinical integration is

typically expensive.

slide-5
SLIDE 5
  • 4. Clinical integration

requires substantial provider time and effort w ith no guaranteed financial return.

slide-6
SLIDE 6
  • 5. Obtain input for your

program from major area payers and other potential customers before completing program development.

slide-7
SLIDE 7
  • 6. Ensure you develop a

product customers w ant to buy.

slide-8
SLIDE 8
  • 7. You can’t cram your

product dow n customers’ throats.

slide-9
SLIDE 9
  • 8. Don’t rely on the FTC or

Antitrust Division to tell you w hat to do or how to do it.

slide-10
SLIDE 10
  • 9. Early on, consider

the data you’ll need, how you’ll collect it, how you’ll analyze it, how you’ll report it, and w hat decisions you’ll base on it.

slide-11
SLIDE 11
  • 10. Maximization of

in-netw ork referrals is important.

slide-12
SLIDE 12
  • 11. Try to include some

penalty, bonus, or pay-for-performance feature in the program.

slide-13
SLIDE 13
  • 12. Ability and w illingness

to terminate outlier providers is important.

slide-14
SLIDE 14
  • 13. Not all physicians w ill

w ant to participate in the clinical-integration program.

slide-15
SLIDE 15
  • 14. You’ll probably lose

significant providers.

slide-16
SLIDE 16
  • 15. Consider the possibility,

advantages, and disadvantages of exclusivity.

slide-17
SLIDE 17
  • 16. Consider the advantages

and disadvantages of seeking an advisory

  • pinion.
slide-18
SLIDE 18
  • 17. Remember that the joint

negotiations must be ancillary to the clinical- integration program, NOT vice versa.

slide-19
SLIDE 19
  • 18. Remember that

ancillarity is only the first antitrust hurdle.

slide-20
SLIDE 20
  • 19. Assessing market pow er

can be difficult, but payers w ill let you (or the FTC) know .

slide-21
SLIDE 21
  • 20. Don’t jump the gun in

jointly negotiating.